Roche

24 Oct: Buy Tamiflu and Relenza online to rescue you against the swine flu

As the 2009/2010 influenza season progresses, there is cause for worry. Flu activity is already widespread in 46 states, according to the Center for Disease Control (CDC), and the 2009 novel H1N1 flu virus, popularly known as the “swine flu,” is on the rise. Meanwhile, the swine flu vaccine is difficult to obtain, leaving many unprotected from this new strain. Fortunately, the antiviral treatments Tamiflu and Relenza are still largely effective against the swine flu. Why is there so much worry about pandemic flu this year? Regular flu kills 36,000 people in the US each year, but the swine flu variation has the potential to kill many more. The latest update from the CDC shows that swine flu has caused…

08 Oct: Accutane is off the US market, but Claravis and generic version remain

Millions of people suffer from severe, debilitating acne that does not respond to over-the-counter treatments such as acne washes and benzoyl peroxide, and even acne prescription medications. Ongoing severe acne can cause physical effects such as pain, infection, and scarring, and social and emotional effects such as shame and low self-esteem. According to the Acne Resource Center: Of the 85% of teenagers (between the ages of 12 and 24) that suffer from acne, 25% will have permanent scars ranging from severe to light. The American Dermatologist Association finds that: 20% of all adults have active acne 60 million Americans have active acne 20 million Americans have acne badly enough to cause scars. Acne affects people regardless of age, gender or…

25 Sep: The Fosamax mistrial, and other options in osteoporosis medication

Earlier this month, a closely-watched trial over the osteoporosis drug Fosamax ended in mistrial, to the frustration of nearly everyone involved. The trial was marked by great tension, with a deadlocked jury, reports of threats of physical violence, and a judge-ordered cooling-down period. What could cause such intense drama? Well, this was just one of approximately 900 state and federal cases pending against Fosamax, alleging that that medication causes osteonecrosis of the jaw (the death of jawbone tissue). In large part, the tension in the Manhattan courtroom was that this trial “the first” was supposed to be an indicator of how these hundreds of similar cases might proceed. The other major factor is that it is notoriously difficult to “prove”…